Use of rCBF in diagnosis and follow-up of cerebral vitamin B12 deficiency
✍ Scribed by Dr. Roger Fäldt; Göran Dalfelt; Lars Gustafson; Jarl Risberg; Anna-Karin Thulin
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 479 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
✦ Synopsis
FALDT,*t' GORAN DALFELT, t ' LARS GUSTAFS0N.t' JARL RISBERG,:' AND ANNA-KARIN THUL.IN+' 'Senior registrar. 2Senior registrar, head of the Department of Psychogeriatrics, 3Psychologist, head qf the Neuropsychiatric Laboratory, Psychologist Departments of Internal Medicine* and Psychogeriatricst and the Neuropsychiatric Laboratory, 1 Universir-v of Lund.
📜 SIMILAR VOLUMES
Background. Vitamin B12 assay is part of the routine investigation of dementia, although few studies have investigated the eects of treatment on cognition. We examined the eects of B12 treatment on neuropsychological function and disease progression in patients presenting with dementia or cognitive
Background: Crohn's disease (CD) can commonly involve the terminal ileum, which is the site of B 12 absorption. The aim of this study was to define the prevalence of vitamin B 12 abnormalities in a population with CD and to identify risk factors associated with B 12 abnormalities in CD. ## Methods:
## Abstract ## BACKGROUND To the authors' knowledge, the prevalence of vitamin B12 deficiency among patients with plasma cell dyscrasias (PCD) is largely unknown. Identifying this vitamin deficiency in such patients could help improve their anemia and increase their tolerance to potentially neurot
Vitamin B,, was determined in biological materials by three basically different methods: microbiological assa) with Luctobaeiltus lcichmcmnii, microbiological assay with Esehcrichiu coli and radioassay. The method with E. coli has a relatively low sensitivity to vitamin B,, and in some cases of vita